Celon Pharma S.A.

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 181
EBIT TTM (mln): 20
index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Przychód (mln) 40 72 98 108 129 107 125 102 139 170 162 164
Przychód Δ r/r 0.0% 78.6% 36.9% 9.6% 19.7% -16.8% 16.9% -18.4% 36.2% 21.7% -4.5% 1.5%
Marża brutto 80.2% 79.4% 79.3% 72.1% 77.9% 77.2% 77.5% 77.2% 77.0% 63.6% 59.0% 59.4%
EBIT (mln) 2 22 29 47 47 26 36 7 37 -14 -35 -27
EBIT Δ r/r 0.0% 848.9% 33.0% 61.6% -0.3% -44.8% 37.0% -80.6% 433.7% -137.1% 154.2% -21.6%
EBIT (%) 5.8% 30.7% 29.8% 43.9% 36.5% 24.3% 28.4% 6.7% 26.4% -8.1% -21.5% -16.6%
Koszty finansowe (mln) 0 0 0 0 1 0 1 0 1 2 2 3
EBITDA (mln) 7 26 34 54 61 49 56 28 68 28 9 23
EBITDA(%) 16.6% 36.7% 35.0% 50.2% 47.1% 45.3% 44.4% 27.3% 48.6% 16.3% 5.8% 13.8%
Podatek (mln) 1 4 6 9 9 5 8 -4 1 -3 3 8
Zysk Netto (mln) 1 18 52 37 38 26 30 12 21 -12 -39 -28
Zysk netto Δ r/r 0.0% 1246.7% 190.7% -28.8% 1.7% -32.2% 15.9% -59.8% 80.1% -154.0% 238.4% -28.4%
Zysk netto (%) 3.3% 25.1% 53.2% 34.6% 29.4% 23.9% 23.7% 11.7% 15.4% -6.8% -24.3% -17.1%
EPS 0.04 0.6 1.74 0.83 0.84 0.57 0.66 0.27 0.48 -0.25 -0.77 -0.55
EPS (rozwodnione) 0.0445 0.6 1.74 0.83 0.84 0.57 0.66 0.27 0.48 -0.25 -0.77 -0.55
Ilośc akcji (mln) 33 30 30 45 45 45 45 45 45 47 51 51
Ważona ilośc akcji (mln) 30 30 30 45 45 45 45 45 45 47 51 51
Waluta PLN PLN PLN PLN PLN PLN PLN PLN PLN PLN PLN PLN